Management tracks

Oncology company Sorrento Therapeutics Inc. (NASDAQ:SRNE) said EVP and chief commercial officer George Uy will step down at the end of July to become CEO of an undisclosed start-up.

Rare disease play Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) hired John Pinion as SVP of analytical sciences and research and chief quality operations officer. Pinion was SVP and global head of quality and compliance at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). ...